Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

NCT05734040 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

478

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: OVX836 480µg
BIOLOGICAL: Fluarix Tetra
BIOLOGICAL: Afluria Quad
BIOLOGICAL: Placebo

Sponsor

Osivax

Collaborators

[object Object]
[object Object]